Overview
Adcirca is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to improve exercise in cases of pulmonary arterial hypertension. Adcirca may be referred to by its drug name, tadalafil…

Overview
Adempas is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to improve exercise and function in adult cases of chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary…

Overview
Aldactone is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat hypertension, heart failure, edema, and other conditions. In cases of pulmonary hypertension, Aldactone may be…

Overview
Alyq is approved by the U.S. Food and Drug Administration (FDA) for the treatment of pulmonary arterial hypertension (PAH) to improve exercise ability. People eligible for this treatment typically have New York…

Overview
Some people with advanced pulmonary arterial hypertension (PAH) and severe right heart failure may be candidates for atrial septostomy surgery. Atrial septostomy can relieve pressure in the right side of the…

Overview
Bumex is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat edema associated with congestive heart failure and other conditions. In cases of pulmonary hypertension, Bumex may be…

Overview
Cardizem is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat hypertension, chronic stable angina, and angina due to coronary artery spasm. Cardizem is sometimes prescribed to…

Overview
Coumadin is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat and prevent thromboembolic events. Coumadin may also be prescribed in cases of pulmonary hypertension, especially…

Overview
Digoxin is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with mild to moderate heart failure and atrial fibrillation. It is also approved to treat children with…

Overview
Flolan is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to improve exercise capacity in cases of pulmonary arterial hypertension (PAH). Flolan may be referred to by its drug name…

Overview
Heart-lung transplant may be an option for some people with end-stage heart and lung disease due to pulmonary hypertension (PH). However, heart-lung transplant also poses significant risk for serious…

Overview
Lanoxin is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat mild to moderate heart failure and atrial fibrillation in adults. Lanoxin may also be prescribed in cases of…

Overview
Letairis is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to improve exercise capacity and limit disease progression in cases of pulmonary arterial hypertension (PAH). Letairis is…

Overview
Liqrev is approved by the U.S. Food and Drug Administration (FDA) for the treatment of pulmonary arterial hypertension (PAH). Liqrev is prescribed to improve exercise ability and delay clinical worsening in…

Overview
Lung transplant can prolong survival and improve lung function and quality of life in some people with pulmonary hypertension (PH). However, lung transplant also poses significant risk for serious complications…

Overview
Metolazone is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat hypertension and edema associated with congestive heart failure. In cases of pulmonary hypertension, Metolazone…

Overview
In some people with pulmonary hypertension (PH), the disease is caused by damage or a defect of the mitral valve of the heart. Mitral valve surgery can potentially be an effective treatment for PH in certain…